Pfizer Ventures, based in New York, backs life sciences startups at Seed, Series A, and Series B, can lead rounds, and writes checks from $3 million to $30 million.
6 people on the investing team, 6 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Pfizer Ventures reports entry at seed, series a, series b.
Pfizer Ventures reports checks of $3M to $30M.
Yes. Pfizer Ventures says it can lead.
Michael C. Diem (Senior Managing Partner), Anthony Barry (Partner), Christopher O'Donnell (Partner), Irena Melnikova (Partner), Marie-Claire Peakman (Partner), Rana Al-Hallaq (Partner).
No recent activity since September 2026.
Work at Pfizer Ventures? Claim or correct this profile.